$Ironwood Pharmaceuticals (IRWD.US)$ fly baby

$Ironwood Pharmaceuticals (IRWD.US)$ Will this company go bankrupt? Stocks have fallen so much

$Ironwood Pharmaceuticals (IRWD.US)$ is it worth buy this stock now?

$Ironwood Pharmaceuticals (IRWD.US)$ Reuters· 1 min ago
Ironwood Pharmaceuticals Initiates Apraglutide Nda Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

$United Therapeutics (UTHR.US)$  Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$  Phase 3
$Liquidia (LQDA.US)$  Phase 3
$United Therapeutics (UTHR.US)$  Phase 3
$MorphoSys (MOR.US)$  Phase 3
$Immunocore (IMCR.US)$  Phase 3
$Crinetics (CRNX.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$AstraZeneca (AZN.US)$  Phase 3
$Capricor Therapeutics (CAPR.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3...

$Ironwood Pharmaceuticals (IRWD.US)$ shares sank almost 40% after the drugmaker said its global phase III trial of Apraglutide, a treatment for short bowel syndrome, missed two of its four secondary goals.
That muddies the prospects for the company that's seeking to expand its product pipeline beyond Linzess.
Ironwood, which has been operating at a loss, sourced almost ll of its $117.6 million revenue in 2023 from its collaborati...

🎯 Ph 3 readouts in Q1 2024...
$Pfizer (PFE.US)$  Phase 3
$Palatin Technologies (PTN.US)$  Phase 3
$Annovis Bio (ANVS.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3
$Atea Pharmaceuticals (AVIR.US)$  Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$  Phase 3
$Alnylam Pharmaceuticals (ALNY.US)$  Phase 3
$Axsome Therapeutics (AXSM.US)$  Phase 3
$ $Novocure (NVCR.US)$  Phase 3
$ROCHE HOLDING AG (RHHBY.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$ACADIA Pharmaceuticals (ACAD.US)$  Phase 3
$Sellas Life Sciences (SLS.US)$...

$Pfizer (PFE.US)$  Phase 3
$Regenxbio (RGNX.US)$  Phase 3
$Annovis Bio (ANVS.US)$  Phase 3
$Atea Pharmaceuticals (AVIR.US)$  Phase 3
$Ironwood Pharmaceuticals (IRWD.US)$  Phase 3
$Alnylam Pharmaceuticals (ALNY.US)$  Phase 3
$Vertex Pharmaceuticals (VRTX.US)$  Phase 3
$KalVista Pharmaceuticals (KALV.US)$  Phase 3
$Axsome Therapeutics (AXSM.US)$  Phase 3
$Novocure (NVCR.US)$  Phase 3
$ROCHE HOLDING AG (RHHBY.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$Applied Therapeutics (APLT.US)$  Phase 3
$ACADIA Pharmaceuticals (ACAD.US)$  Phase 3...

$Pfizer (PFE.US)$  Phase 2
$Leap Therapeutics (LPTX.US)$  Phase 2
$Vera Therapeutics (VERA.US)$  Phase 2b
$4D Molecular Therapeutics (FDMT.US)$  Phase 2
$Adverum Biotechnologies (ADVM.US)$  Phase 2
$Denali Therapeutics (DNLI.US)$  Phase 2
$Akero Therapeutics (AKRO.US)$  Phase 2b
$Spruce Biosciences (SPRB.US)$  Phase 2
$Xencor (XNCR.US)$  Phase 2
$Alnylam Pharmaceuticals (ALNY.US)$  Phase 2
$Harmony Biosciences (HRMY.US)$  Phase 2
$Annexon (ANNX.US)$  Phase 2a
$Roivant Sciences (ROIV.US)$...